Ph.D., pharmacoeconomics and policy, M.S., health care regulation and law, and M.A., economics, University of Southern California; B.S., Peking University
Summary of Experience
Dr. Wu is a health economist specializing in health economics, outcomes, and market access issues related to pharmaceuticals, biologics, and devices. He has broad experience consulting to pharmaceutical and device companies, payers, providers, and government agencies globally. Dr. Wu has extensive experience in health economics and outcomes research strategy development; analysis of medical claims and clinical trial data, patient chart review, patient surveys and physician surveys, and economic modeling to support treatment guideline development; global formulary and reimbursement submission; step therapy design; appropriate generics and biosimilars use; and investigations in comparative effectiveness, personalized medicine, direct and indirect resource utilization and costs, work loss, quality of life, treatment pattern, disease prevalence, and adverse events. His interests also include developing new methods and statistical tests to address challenges in health care research and application of medical big data. Dr. Wu sits on the advisory board of the Health Economic Evaluation Center of the Chinese Medical Doctor Association. He was a coeditor of PharmacoEconomics' special issue on health care in China.